(a)

any amounts in respect of appropriations to be made from profit of the Cell in respect of the reporting period most recently ended, including dividends, bonuses, pensions and welfare charges that are determined on the basis of the profit of that reporting period, whether or not the amounts have been approved by the Insurer for payment;

(b)

Owners’ Equity in a Takaful Insurer that does not, under the constitutional documents of the Insurer or the terms of insurance contracts or both, participate in the surpluses and losses of Takaful business;

(c)

the amount of any investment by the Insurer or by a Subsidiary of the Insurer, in the Insurer’s own shares, where that investment or the Subsidiary concerned is a Cellular Asset;

(d)

the amount of any tax liability that would be attributable to unrealised gains on investments that are Cellular Assets, if those gains were realised;

(e)

the amount of deferred acquisition costs that are Cellular Assets;

(f)

the amount of any deferred tax asset that is a Cellular Asset;